Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

86.70USD
22 Nov 2017
Change (% chg)

$-0.05 (-0.06%)
Prev Close
$86.75
Open
$86.50
Day's High
$86.91
Day's Low
$86.24
Volume
131,854
Avg. Vol
401,445
52-wk High
$91.73
52-wk Low
$63.69

Summary

Name Age Since Current Position

Marry Brlas

59 2016 Independent Chairman of the Board

John Hendrickson

54 2017 President, Director

Ronald Winowiecki

50 2017 Acting Chief Financial Officer

James Michaud

61 2016 Chief Human Resource Officer, Executive Vice President

Thomas Farrington

59 2015 Executive Vice President, Chief Information Officer

Todd Kingma

57 2006 Executive Vice President, General Counsel, Company Secretary

Sharon Kochan

48 2012 Executive Vice President, General Manager - Consumer Healthcare International

Jeffrey Needham

60 2009 Executive Vice President, General Manager - Consumer Healthcare Americas

Svend Andersen

55 2017 Executive Vice President and President - Consumer Healthcare International

Ronald Janish

51 2015 Executive Vice President - Global Operations and Supply Chain

Grainne Quinn

47 2016 Executive Vice President, Chief Medical Officer

Paul Weninger

53 2015 Executive Vice President - Global Quality Operations

John Wesolowski

49 2016 Executive Vice President, President - RX

Bradley Alford

61 2017 Independent Director

Rolf Classon

71 2017 Independent Director

Gary Cohen

57 2009 Independent Director

Adriana Karaboutis

54 2017 Independent Director

Jeffrey Kindler

61 2017 Independent Director

Donal O'Connor

66 2014 Independent Director

Geoffrey Parker

52 2016 Independent Director

Theodore Samuels

62 2017 Independent Director

Jeffrey Smith

45 2017 Independent Director

Bradley Joseph

2017 IR Contact Officer

Biographies

Name Description

Marry Brlas

Ms. Marry Laurie Brlas is Independent Chairman of the Board of Perrigo Company Public Limited Company., since April 25, 2016. She has been a director of Perrigo since August 2003 and was appointed Chairman of the Board in April 2016. Ms. Brlas served as Executive Vice President and Chief Financial Officer of Newmont Mining Corporation from September 2013 until October 2016, and she retired from Newmont Mining Corporation on December 31, 2016. From 2006 through 2013, Ms. Brlas held various positions with Cliffs Natural Resources, most recently as Executive Vice President and President Global Operations. Prior to this role, she served as Chief Financial Officer. Prior to that, Ms. Brlas served as Senior Vice President and Chief Financial Officer of STERIS Corporation, a provider of healthcare products, from 2000 through 2006. From 1995 through 2000, Ms. Brlas held various positions with Office Max, Inc., most recently as Senior Vice President and Corporate Controller. Since October 2016, Ms. Brlas has served as a director on the board of Calpine, a power company based in Houston, Texas. Ms. Brlas also served as a director for Nova Chemicals from September 2008 to July 2009.

John Hendrickson

Mr. John T. Hendrickson serves as President, Director at Perrigo Company Public Limited Company. On June 5, 2017, the Company has officially announced that he has decided to retire. A further official announcement will follow in due course. His work experience includes the following roles: President at the Company (since October 22, 2015), Executive Vice President - Global Operations and Supply Chain at the Company (March 27, 2007-October 22, 2015), Executive Vice President and General Manager of Perrigo Consumer Healthcare (August 2003-March 27, 2007), Executive Vice President of Operations at the Company (October 1999-2003), Research and Development Group Leader at Procter & Gamble (1987-1989) and R&D Engineer (1985-1987). He holds a Bachelor of Science degree in Chemistry from Hope College, a Bachelor of Science degree in Chemical Engineering from University of Michigan and a MBA degree from University of Notre Dame.

Ronald Winowiecki

Mr. Ronald (Ron) L. Winowiecki is Acting Chief Financial Officer of the Company. Mr. Winowiecki was appointed Acting CFO in February 2017. He served as Senior Vice President of Business Finance at Perrigo since January 2014. Before serving as SVP, Mr. Winowiecki was Perrigo’s Vice President for Treasury and Accounting Shared Services from September 2011 to December 2013 and the company’s Corporate Vice President Treasurer from October 2008 to August 2011.

James Michaud

Mr. James R. Michaud is Chief Human Resource Officer, Executive Vice President of the Company. Mr. Michaud was named Executive Vice President, Chief Human Resources Officer in August 2016. Immediately prior to joining Perrigo, Mr. Michaud was President of Human Resources Strategies, a consulting company focused on providing business based human resource strategies to a wide variety of companies in multiple industries. His corporate career spanned senior human resource roles in Alcoa, Arcelor Mittal Steel, and most recently, Cliffs Natural Resources, where he served as Executive Vice President, Chief Human Resources Officer from 2010 to 2014.

Thomas Farrington

Mr. Thomas M. Farrington is Executive Vice President, Chief Information Officer of the Company. Mr. Farrington was named Executive Vice President and Chief Information Officer in November 2015. He formerly served as Senior Vice President and Chief Information Officer from October 2006 to November 2015.

Todd Kingma

Mr. Todd W. Kingma is Executive Vice President, General Counsel, Company Secretary of the Company. Mr. Kingma was named Executive Vice President, General Counsel and Secretary in May 2006. He served as Vice President, General Counsel and Secretary from August 2003 to May 2006.

Sharon Kochan

Mr. Sharon Kochan is Executive Vice President, General Manager - Consumer Healthcare International of the Company. Mr. Kochan was named Executive Vice President and General Manager, Consumer Healthcare International in August 2012. He served as Executive Vice President, General Manager of Prescription Pharmaceuticals from March 2007 to July 2012 and as Senior Vice President of Business Development and Strategy from March 2005 to March 2007. Mr. Kochan was Vice President, Business Development of Agis Industries (1983) Ltd. from July 2001 until the acquisition of Agis by the Company in March 2005.

Jeffrey Needham

Mr. Jeffrey R. Needham is Executive Vice President, General Manager - Consumer Healthcare Americas of the Company. Mr. Needham was named Executive Vice President, General Manager of Consumer Healthcare Americas in October 2009. He served as Senior Vice President of Commercial Business Development for Consumer Healthcare from March 2005 through October 2009. Previously, he served as Senior Vice President of International from November 2004 to March 2005. He served as Managing Director of Perrigo’s U.K. operations from May 2002 to November 2004 and as Vice President of Marketing from 1993 to 2002.

Svend Andersen

Mr. Svend Andersen is Executive Vice President and President - Consumer Healthcare International of the Company. Mr. Andersen was named Executive Vice President and President, Consumer Healthcare International in February 2017. Prior to joining Perrigo, Mr. Andersen served as Executive Vice President – Europe for LEO-Pharma. Prior to that, he led Hospira, Inc.’s Europe, Middle East and Africa (“EMEA”) business, was responsible for the Western European division’s pharmaceuticals, generics, OTC and hospital products businesses at Actavis, and also led Alpharma’s EMEA businesses prior to its acquisition by Actavis.

Ronald Janish

Mr. Ronald Janish is Executive Vice President - Global Operations and Supply Chain of the Company. He served as Senior Vice President of International and Rx Operations from 2012 until 2015 and as Managing Director of Perrigo’s Australian operations from 2010 to 2012. Previously, he held Senior Vice President roles for Perrigo in International Market Development, China Business Development and Global Procurement.

Grainne Quinn

Dr. Grainne Quinn, M.D., is Executive Vice President, Chief Medical Officer of the Company. Ms. Quinn was named Executive Vice President in July 2016 and has served as Chief Medical Officer since November 2015. Prior to that she served as Vice President and Head of Global Patient Safety from January 2014 until November 2015. Dr. Quinn was Vice President and Head of Global Pharmacovigilance and Risk Management for Elan from April 2009 until December 2013 when the Company acquired Elan.

Paul Weninger

Mr. Paul Weninger is Executive Vice President - Global Quality Operations of the Company. Mr. Weninger was named Executive Vice President of Global Quality Operations in December 2015. He served as Senior Vice President, U.S. Quality Operations from 2013 to 2015; Vice President, Consumer Healthcare and Rx Quality Operations, U.S. and Asia Pacific from 2010 to 2013; Vice President, Global CHC Quality Operations from 2007 to 2010.

John Wesolowski

Mr. John Wesolowski is Executive Vice President, President - RX of the Company. Mr. Wesolowski was named Executive Vice President, President RX in November 2016. He previously was named as Acting General Manager, RX, in July 2016 and served in that capacity until November 2016. Previously, he served as Senior Vice President of RX Commercial Operations, from 2013 until July 2016. Mr. Wesolowski joined Perrigo in February 2004 as the Vice President, RX Sales and Marketing and was subsequently promoted to the Senior Vice President of RX Sales and Marketing in 2012.

Bradley Alford

Mr. Bradley A. Alford is Independent Director of the Company. Mr. Alford has been a director of Perrigo since February 2017. Mr. Alford joined Advent International Corporation, a global private equity firm, in 2014 as an Industry Advisor and moved to Operating Partner in March of 2016. From 2006 to 2013, Mr. Alford was Chairman and Chief Executive Officer of Nestlé USA. Mr. Alford also served as CEO and President of Nestlé Brands Company. He also serves as a director of Avery Dennison Corporation since April 2010, and Conagra Brands, Inc. since July 2015. Throughout his career, Mr. Alford has been focused on developing brands, initiatives to improve processes and facilitate best practices across an organization.

Rolf Classon

Mr. Rolf A. Classon has been appointed Independent Director at Perrigo Company Public Limited Company., effective May 2, 2017. Mr. Classon served as Interim President and Chief Executive Officer of Hillenbrand Industries, a global diversified industrial company, from May 2005 until March 2006. From 2002 until June 2004, Mr. Classon served as Chairman of the Executive Committee of Bayer Healthcare AG, a subsidiary of Bayer AG. Mr. Classon served as President of Bayer Diagnostics from 1995 to 2002 and as Executive Vice President from 1991 to 1995. Prior to 1991, Mr. Classon held various management positions with Pharmacia Corporation. Mr. Classon serves as a director of Fresenius Medical Care AG and Co. since May 2012, Tecan Group, Ltd. since April 2009, Catalent, Inc. since July 2014, and Hill-Rom Holdings, Inc. since July 2002. Mr. Classon also served as a director of Aerocrine AB, Stockholm from May 2013 to July 2015 and Auxilium Pharmaceuticals from July 2005 to January 2015.

Gary Cohen

Mr. Gary M. Cohen is Independent Director of the Company. Since 2006, he has served as Executive Vice President of Becton, Dickinson and Company (“BD”), a provider of medical supplies, devices, laboratory equipment and diagnostic systems. He also served as President of BD Medical, one of three business segments of BD, from 1999 until 2006. Mr. Cohen has been an executive officer of BD in various capacities since 1996. Mr. Cohen presently serves as a director and co-chair of GBCHealth; director, founder and president of Together for Girls, Inc.; and a director of the following additional nonprofit organizations: the Centers for Disease Control and Prevention (CDC) Foundation; the United States Fund for UNICEF; the Federal Drug Agents Foundation; and the Global Partnership to End Violence Against Children. He also serves as chairperson of the CDC Corporate Roundtable on Global Heath Threats and Scientific Advisor for Grand Challenges Canada.

Adriana Karaboutis

Ms. Adriana (Andi) Karaboutis is Independent Director at Perrigo Company Public Limited Company., since May 2, 2017. Ms. Karaboutis served as Executive Vice President, Technology, Business Solutions and Corporate Affairs at Biogen Inc., an independent biotechnology company from December 2015 to February 2017, and as Executive Vice President, Technology and Business Solutions from September 2014 to December 2015. Prior to that, Ms. Karaboutis served as Vice President and Global Chief Information Officer of Dell, Inc., a global technology company, from 2011 to September 2014, and as Vice President of IT, Global Operations and Technology from 2010 to 2011. Ms. Karaboutis spent more than 20 years at General Motors Corporation and Ford Motor Company in various leadership positions, including computer-integrated manufacturing, supply chain operations and information technology. In addition, Ms. Karaboutis has been a director of Advance Auto Parts, Inc. since 2015 and Blue Cross Blue Shield of Massachusetts since 2016.

Jeffrey Kindler

Mr. Jeffrey B. Kindler serves as Independent Director of the Company. Mr. Kindler has been a director of Perrigo since February 2017. Mr. Kindler has been a Venture Partner at Lux Capital, a venture capital firm, since 2012, and has served as CEO of Centrexion Corporation, a privately held bio therapeutics company that develops pain therapies, since 2013. In addition, Mr. Kindler serves as Executive Chairman of vTv, Managing Director at Starboard Capital Partners (unrelated to Starboard Value LP or any of its affiliates), and advisor to a number of healthcare companies. Prior to this, Mr. Kindler was Chairman and CEO of Pfizer, Vice President of Litigation and Legal Policy at General Electric Company, Executive Vice President and General Counsel at McDonald’s, and President at Partner Brands. In addition, Mr. Kindler has served as a director of Intrexon since 2011, also serving as Chair of the Audit Committee, vTv Therapeutics since 2015, and Siga Technologies since 2013, as well as a number of privately held companies.

Donal O'Connor

Mr. Donal O'Connor is Independent Director of the Company. He has been a director of Perrigo since November 2014 and was previously a director of Elan Corporation, plc from May 2008 until Perrigo’s acquisition of Elan in December 2013. During Mr. O’Connor’s tenure on Elan’s board of directors, he served on Elan’s Audit and Leadership, Development and Compensation Committees. He was previously a senior partner of PwC in Ireland from 1995 until 2007. He was also a member of PwC Global Board from 2003 to 2008 and was a former chairman of the PwC Eurofirms Board. From December 2008 to May 2012, Mr. O’Connor served as a director for Readymix plc, an Irish concrete manufacturer and supplier, also serving on its audit and remuneration committees. From December 2008 to June 2010, Mr. O’Connor served as the government appointed Chairman of Anglo Irish Bank plc. Mr. O’Connor has been a director of Theravance Biopharma, Inc. since October 2015 and also holds directorships in a number of private Irish companies.

Geoffrey Parker

Mr. Geoffrey M. Parker is the Independent Director of the Company. Since April 2017, Mr. Parker has served as Chief Financial Officer of Tricida, Inc., a biopharmaceutical company. Mr. Parker previously served as Chief Financial Officer of Anacor Pharmaceuticals, a bio pharmaceutical company, from September 2010 to May 2015. From 1997 to 2009, Mr. Parker led the West Coast Healthcare Investment Banking practice at Goldman Sachs, where he advised leading companies in the biotechnology, life science tools and medical device industries. Mr. Parker has served as a member of the board of directors of Genomic Health, Sunesis Pharmaceuticals and ChemoCentryx since June 2016, March 2016, and December 2009, respectively.

Theodore Samuels

Mr. Theodore R. Samuels is an Independent Director of the Company., since January 4, 2017. From 1981 to 2017, Mr. Samuels was an investor at Capital Group, a financial services company, and he served as President of Capital Guardian Trust Company, an affiliated company of Capital Group, from 2010 to 2016. While at Capital Group, he also served on The Capital Group Board, Audit Committee and Finance Committee, as well as on numerous management and investment committees. Mr. Samuels has been a director for Stamps.com since January 2017 and a director of Bristol-Myers Squibb since February 2017.

Jeffrey Smith

Mr. Jeffrey C. Smith is Independent Director of the Company. Mr. Smith has been a director of Perrigo since February 2017. Mr. Smith is a Managing Member, CEO, and Chief Investment Officer of Starboard Value LP. Mr. Smith has extensive experience in best-in-class corporate governance practices and significantly improving value at underperforming companies. He currently serves as Chairman of the Board of Advance Auto Parts, where he has been as a director since November 2015, and has also been on the board of Yahoo! Inc. since April 2016. Mr. Smith was Chairman of the Board of Darden Restaurants from October 2014 to April 2016. In addition, during the past five years, Mr. Smith has served on the boards of Quantum Corporation, Office Depot, Inc., Regis Corporation and Surmodics, Inc.

Bradley Joseph